Genetic Predisposition to Lung Cancer May Be Greater in Women Than in Men
New research suggests that genetic susceptibility to lung cancer is greater in women, and a family history of cancer predicts lung cancer risk.
Iruplinalkib Outperforms Crizotinib in ALK+, Advanced NSCLC
Iruplinalkib, a novel ALK inhibitor, was more effective than crizotinib in a phase 3 trial of patients with advanced, ALK-positive non-small cell lung cancer.
Breast Cancer Awareness Month: The History and Impact
When did Breast Cancer Awareness Month first begin? Discover its impact on awareness and research in the years since its inception.
Fine Particular Matter Linked to Increase in Breast Cancer Risk
Significant increase in risk seen for ER-positive breast cancer, but not ER-negative tumors.
Fear of Recurrence in Breast Cancer Survivors Increases Supportive Care Needs
Cross-sectional survey results demonstrate that fear of cancer recurrence varies across 5 domains in breast cancer survivors.
Incidence of Lung Cancer Subtypes Varies by Region
Incidence rates of lung cancer subtypes vary across global regions, data suggest.
Aphexda Approved for Stem Cell Mobilization for ASCT in Multiple Myeloma
Aphexda is expected to be available in September 2023.
Opioid-Free Discharge Feasible After Pancreatectomy
In a recent study, there was an increase in the percentage of patients discharged opioid-free.
Hepatitis C Virus Still Leading Cause of Hepatocellular Cancer in Men
Since 2017, the leading cause of HCC among women is NAFLD; however, the leading cause among men remains HCV.
Multidisciplinary Approach to Immune-Related AE Management in NSCLC Improves Outcomes
Researchers investigated the effects of multidisciplinary clinical management of IMDC in patients with NSCLC undergoing treatment with immune checkpoint inhibitors.
- Loading...
